Search clinical trials for: gemtuzumab ozogamicin (GO)

Total 991 results

Genzyme, a Sanofi Company

Terminated

Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Macedonia, The Former Yugoslav Republic of, Bosnia and Herzegovina, Israel
Chronic Lymphocytic Leukemia Research Consortium
Bayer

Unknown

Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy (CRC005)

B-Cell Chronic Lymphocytic Leukemia

United States
University of North Carolina, Chapel Hill
Midmark Corporation; Monitored Therapeutics, Inc

Completed

Assessing Adherence to Home Telemedicine in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States
Clalit Health Services

Unknown

Validity of TURN 180 Test to Distinguish Between the Fallers and Non-Fallers

Elderly | Falls | Postural Balance

Israel
Gilead Sciences

Completed

Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis

Myelofibrosis

United States
Tufts Medical Center

Completed

Audio-Visual Relaxation Technology for Pediatric Amplified Musculoskeletal Pain Syndrome

Complex Regional Pain Syndromes | Reflex Sympathetic Dystrophy | Amplified Musculoskeletal Pain Syndrome

United States
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Recruiting

Testing a New Imaging Agent to Identify Cancer

HER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of Breast

United States
Memorial Sloan Kettering Cancer Center

Completed

Imaging With a New Agent That Finds a Cancer Protein Called HER2

HER2-positive Carcinoma | HER2-positive Primary Malignancy

United States
Columbia University

Completed

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia (AML/MDS/JMML)

Juvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Biocad

Active, not recruiting

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

Breast Cancer

Russian Federation
Genzyme, a Sanofi Company

Terminated

LEMTRADA Pregnancy Registry in Multiple Sclerosis

Multiple Sclerosis

United States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
Northwestern University
Genzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.

Completed

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

Lymphoma

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab

Breast Cancer

United States
University of Oslo

Completed

Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction

Opiate Dependence

Norway
National Cancer Institute (NCI)

Completed

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Peripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)

United States
Genzyme, a Sanofi Company

Completed

Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL) (ECO-1)

Leukemia, Lymphocytic, Chronic, B-Cell

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Roche Pharma AG

Completed

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma (TRAP)

Esophageal Carcinoma

Netherlands
Pfizer

Completed

InO - A Retrospective Study of UK Patients With Leukaemia (InO)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

United Kingdom
Rush University Medical Center

Recruiting

Church-based Intervention to Improve Physical Function in African Americans

Physical Function | Multiple Chronic Conditions

United States
University College, London
British Heart Foundation; Headspace Meditation Limited; Technical University...

Unknown

A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace

Well-being, Work Stress

United Kingdom
M.D. Anderson Cancer Center
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Leukemia

United States
Fudan University

Completed

Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab

Breast Cancer

China
Assistance Publique - Hôpitaux de Paris

Completed

Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia (Campath)

Acute Lymphocytic Leukemia

France
Genzyme, a Sanofi Company

Completed

A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

Japan
St. Jude Children's Research Hospital

Completed

Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome

Severe Combined Immunodeficiency

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia

United States
Abby Braitman
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrolling by invitation

Personalized Feedback After Alcohol Health Education for Members of Greek Life (GREEK Study)

College Student Drinking

United States
Istanbul Medeniyet University

Unknown

Turkish Version of the Mini-BESTest: Transcultural Adaptation and Validation Study in Stroke Patients

Stroke | Balance; Distorted

Turkey
Tanta University

Recruiting

Nebulization Versus Spray-as-You-Go Airway Topical Anesthesia Using Dexmedetomidine and Lidocaine Mixture During Awake Flexible Fiberoptic Intubation in Temporomandibular Ankylosis

Dexmedetomidine | Lidocaine | Temporomandibular Ankylosis | Nebulization | Spray-as-You-Go

Egypt
All India Institute of Medical Sciences, New Delhi

Completed

Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Bronchoscopy (CRISP)

Pulmonary Disease

India
Hospices Civils de Lyon

Not yet recruiting

PETRA: PErtuzumab and Trastuzumab Biosimilars Real Life Association for the First Line Treatment of HER2-positive Metastatic Breast Cancer, an Observational Prospective Multicenter Study (PETRA)

HER-2 Positive Breast Cancer

France
Abby Braitman
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Timing Personalized Feedback After Alcohol Health Education (TIME)

College Student Drinking

United States
Assiut University

Unknown

Assessment of Skeletal Muscle Dysfunction in Patient With Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease | Skeletal Muscle Dysfunction
Esslingen University of Applied Sciences
Federal Ministry of Health, Germany

Completed

Trial to Evaluate the Effects of the German eCHECKUP TO GO in Students (PsSt)

Alcohol Consumption

Germany
Pfizer
UCB Pharma

Completed

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia

United States
Hoffmann-La Roche

Completed

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer (PHranceSCa)

HER2-Positive Early Breast Cancer

United States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC

HER2-positive Breast Cancer

China
Guangdong Provincial People's Hospital

Recruiting

Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study)

Neoadjuvant Therapies for HER2+ Breast Cancer

China
Genentech, Inc.

Approved for marketing

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

HER2-positive Breast Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Institut für Klinische Krebsforschung IKF GmbH...
Trium Analysis Online GmbH

Completed

FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer (PETRARCA)

Stomach Cancer | Gastroesophageal Junction Cancer

Germany
Leeds Cancer Centre at St. James's University Hospital

Completed

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission

Leukemia

United Kingdom
New York Medical College

Terminated

Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML (High Risk)

Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Myelodysplastic Syndrome

United States
Children's Hospital Los Angeles
AppliedVR Inc.

Suspended

Virtual Reality to Reduce Pre-Operative Anxiety

Pain | Anxiety | Virtual Reality | Ambulatory Surgery | Augmented Reality | IV Stick | Mask Induction

United States
Region Skane
Lund University; Capio Group; Doctrin; Capio Go

Completed

Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care (DOCACUP)

Cough | Influenza | Common Cold | Sore Throat | Dysuria

Sweden
University of Oxford
Boehringer Ingelheim; Prostate Cancer UK

Active, not recruiting

Windows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN) (WINGMEN)

Prostate Cancer

United Kingdom
Grupo Cooperativo de Estudio y Tratamiento de las...

Completed

Prospective Study of Mylotarg and G-CSF in Acute Myeloid Leukemia Treatment

Novo Acute Myeloid Leukemia

Spain
Memorial Sloan Kettering Cancer Center
United States Department of Defense; Genentech, Inc.

Completed

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Breast Cancer Metastases | HER2 Positive Breast

United States
Pfizer

Approved for marketing

Inotuzumab Ozogamicin - PF-05208773
Centre Henri Becquerel

Completed

Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma (SARCOPENIE)

Diffuse Large B Cell Lymphoma | Grade IIIB Follicular Lymphoma

France

Search clinical trials for: gemtuzumab ozogamicin (GO)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations